Publicaciones en las que colabora con Marta Prieto Vicente (22)

2022

  1. Protective Effect of Quercetin 3-O-Glucuronide against Cisplatin Cytotoxicity in Renal Tubular Cells

    Molecules, Vol. 27, Núm. 4

2021

  1. A micellar formulation of quercetin prevents cisplatin nephrotoxicity

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-14

  2. Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy

    Journal of Clinical Medicine, Vol. 10, Núm. 21

2020

  1. Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury

    Scientific Reports, Vol. 10, Núm. 1

  2. Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity

    European Journal of Clinical Pharmacology, Vol. 76, Núm. 1, pp. 23-33

  3. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations

    Biomedicine and Pharmacotherapy, Vol. 121

2019

  1. Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy

    International Journal of Molecular Sciences, Vol. 20, Núm. 19

2018

  1. N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity

    Toxicology and Applied Pharmacology, Vol. 349, pp. 83-93

2017

  1. Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues

    Food and Chemical Toxicology, Vol. 107, pp. 226-236

  2. Key role of oxidative stress in animal models of aminoglycoside nephrotoxicity revealed by a systematic analysis of the antioxidant-to-nephroprotective correlation

    Toxicology, Vol. 385, pp. 10-17

2016

  1. Assessment of Kidney Graft Function Evolution Measured by Creatinine and Cystatin C

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2913-2916

2015

  1. Acute tubular necrosis: An old term in search for a new meaning within the evolving concept of acute kidney injury

    New Horizons in Translational Medicine, Vol. 2, Núm. 4-5, pp. 110-117

2014

  1. Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability

    Journal of Investigative Dermatology, Vol. 134, Núm. 1, pp. 247-255

2013

  1. Endoglin Haploinsufficiency Promotes Fibroblast Accumulation during Wound Healing through Akt Activation

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. Subcellular targets of cisplatin cytotoxicity: An integrated view

    Pharmacology and Therapeutics, Vol. 136, Núm. 1, pp. 35-55

2006

  1. Endoglin regulates cyclooxygenase-2 expression and activity

    Circulation Research, Vol. 99, Núm. 3, pp. 248-256

  2. Reduced angiogenic responses in adult endoglin heterozygous mice

    Cardiovascular Research, Vol. 69, Núm. 4, pp. 845-854

2005

  1. Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction

    Kidney and Blood Pressure Research, Vol. 28, Núm. 1, pp. 32-40

  2. Temporal changes in renal endoglin and TGF-β1 expression following ureteral obstruction in rats

    Journal of Physiology and Biochemistry, Vol. 61, Núm. 3, pp. 457-467

2004

  1. Endoglin regulates nitric oxide-dependent vasodilatation.

    The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, Núm. 3, pp. 609-611